Birmingham, West Midlands -- (SBWIRE) -- 01/30/2014 -- Value Penny Stocks issues special report on_ Angie's List Inc (NASDAQ:ANGI), Kulicke and Soffa Industries Inc. (NASDAQ:KLIC), Star Scientific, Inc. (NASDAQ:STSI), Halozyme Therapeutics, Inc. (NASDAQ:HALO).
Angie's List Inc (NASDAQ:ANGI) ended its recent business day with the advanced of 0.24% and closed at the price of $17.06 after opening at $16.86. The stock traded during its last trading session with the total volume of 1.21 million shares, as compared to its average volume of 1.47 million shares. Angies List, Inc. operates a consumer-driven solution for its members to research, hire, rate, and review local professionals for home, health care, and automotive service needs.
Will ANGI Continue To Move Higher? Find out via this report
Kulicke and Soffa Industries Inc. (NASDAQ:KLIC) remained among the day bearish -1.66% and traded with volume of 1.21 million shares in the last session, as compared to average volume of 850,274.00 shares. In comparison with 52 week range of $10.08 - $13.70, it faced lowest price of $11.80 during the last trading session whereas its day highest price was $11.99. The company’s total market capitalization is $898.72 million, along with 75.97 million shares outstanding. Kulicke and Soffa Industries, Inc. designs, manufactures, and sells capital equipment and expendable tools to assemble semiconductor devices, including integrated circuits, discrete devices, light-emitting diodes, and power modules.
Why Should Investors Buy KLIC After the Recent Fall? Just Go Here and Find Out
Star Scientific, Inc. (NASDAQ:STSI) showed 1.21 million shares in volume during the last trading session, while the average trading volume remained 1.65 million shares. The stock kicked off its trading session at $0.73 and closed at $0.734 after rallied 0.42%. Star Scientific, Inc. engages in the development, manufacture, sale, and marketing of nutraceutical dietary supplements and consumer products.
Why Should Investors Buy STSI After The Recent Gain? Just Go Here and Find Out
Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock traded during its last trading session with the total traded volume of 1.21 million shares versus its average volume of 1.63 million shares. The company opened its trade at the price of $16.24 and its closing price was $15.92 after fell -3.43% for the day. Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes.
Has HALO Found The Bottom and Ready To Move Up? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)